Skip to main content
Advanced Technical IVT

microsatellite instability-low

Also written as: MSI-L — microsatellite instability-low

A tumor phenotype characterized by low-level defects in DNA mismatch repair, falling between microsatellite stable and microsatellite instability-high classifications.

Full Definition

Microsatellite instability-low (MSI-L) represents an intermediate category of DNA mismatch repair deficiency where tumors exhibit some microsatellite alterations but do not meet the threshold for MSI-high classification. This classification has uncertain clinical significance in precision oncology, as MSI-L tumors typically do not respond to immune checkpoint inhibitors like MSI-high tumors do. The designation requires careful interpretation in clinical reports, as treatment implications differ significantly from MSI-high tumors. Most guidelines focus primarily on MSI-high vs. microsatellite stable classifications for therapeutic decision-making.

Usage

Usage note: Hyphenate when used as a compound adjective; avoid confusion with MSI-H in clinical contexts.

In Context

  • "The tumor was classified as microsatellite instability-low, indicating uncertain benefit from immunotherapy." — precision oncology report
  • "Editorial note: Distinguish clearly between MSI-L and MSI-H when discussing immunotherapy eligibility." — clinical guideline document

Also known as

MSI-L

Contrasted with

microsatellite stable MSI-high

Don't confuse with

MSI-H microsatellite stable

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON